您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[美股财报]:医美国际2023年度报告 - 发现报告
当前位置:首页/财报/招股书/报告详情/

医美国际2023年度报告

2024-04-25美股财报睿***
医美国际2023年度报告

TableofContents UNITEDSTATES SECURITIESANDEXCHANGECOMMISSION WASHINGTON,D.C.20549 FORM20-F (MarkOne) REGISTRATIONSTATEMENTPURSUANTTOSECTION12(b)OR12(g)OFTHESECURITIESACTOF1934 OR ANNUALREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 ForthefiscalyearendedDecember31,2023OR TRANSITIONREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 OR SHELLCOMPANYREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 Dateofeventrequiringthisshellcompanyreport: Forthetransitionperiodfromto Commissionfilenumber:001-39088 AestheticMedicalInternationalHoldingsGroupLimited (ExactnameofRegistrantasspecifiedinitscharter) N/A (TranslationofRegistrant’snameintoEnglish) CaymanIslands (Jurisdictionofincorporation) 1122NanshanBoulevardNanshanDistrict,Shenzhen GuangdongProvince,China518052 (Addressofprincipalexecutiveoffices) WuGuanhua,ChiefFinancialOfficerE-mail:toby@pengai.com.cn 1122NanshanBoulevardNanshanDistrict,Shenzhen GuangdongProvince,China518052Telephone:+86(755)26650533 (Name,Telephone,E-mailand/orFacsimilenumberandAddressofCompanyContactPerson) Securitiesregisteredortoberegistered,pursuanttoSection12(b)oftheAct TitleofeachclassTradingSymbol(s)Nameofeachexchangeonwhichregistered Americandepositaryshares,eachrepresentingthreeordinarysharesOrdinaryshares,parvalueUS$0.001pershare* AIHTheNASDAQStockMarketLLC *Notfortrading,butonlyinconnectionwiththelistingoftheAmericandepositarysharesonTheNASDAQStockMarketLLC. TableofContents SecuritiesregisteredortoberegisteredpursuanttoSection12(g)oftheAct. None (TitleofClass) SecuritiesforwhichthereisareportingobligationpursuanttoSection15(d)oftheAct. None (TitleofClass) Indicatethenumberofoutstandingsharesofeachoftheissuer’sclassesofcapitalorcommonstockasofthecloseoftheperiodcoveredbytheannualreport: AsofDecember31,2023,therewere143,363,884ordinarysharesissuedandoutstanding. Indicatebycheckmarkiftheregistrantisawell-knownseasonedissuer,asdefinedinRule405oftheSecuritiesAct. YesNo Ifthisreportisanannualortransitionreport,indicatebycheckmarkiftheregistrantisnotrequiredtofilereportspursuanttoSection13or15(d)oftheSecuritiesExchangeActof1934. YesNo Note–CheckingtheboxabovewillnotrelieveanyregistrantrequiredtofilereportspursuanttoSection13or15(d)oftheSecuritiesExchangeActof1934fromtheirobligationsunderthoseSections. Indicatebycheckmarkwhethertheregistrant(1)hasfiledallreportsrequiredtobefiledbySection13or15(d)oftheSecuritiesExchangeActof1934duringthepreceding12months(orforsuchshorterperiodthattheregistrantwasrequiredtofilesuchreports),and(2)hasbeensubjecttosuchfilingrequirementsforthepast90days. YesNo IndicatebycheckmarkwhethertheregistranthassubmittedelectronicallyeveryInteractiveDataFilerequiredtobesubmittedpursuanttoRule405ofRegulationS-Tduringthepreceding12months(orforsuchshorterperiodthattheregistrantwasrequiredtosubmitsuchfiles). YesNo Indicatebycheckmarkwhethertheregistrantisalargeacceleratedfiler,anacceleratedfiler,anon-acceleratedfiler,oranemerginggrowthcompany.Seethedefinitionsof“largeacceleratedfiler,”“acceleratedfiler,”and“emerginggrowthcompany”inRule12b-2oftheExchangeAct. LargeacceleratedfilerAcceleratedfilerNon-acceleratedfilerEmerginggrowthcompanyIfanemerginggrowthcompanythatpreparesitsfinancialstatementsinaccordancewithU.S.GAAP,indicatebycheck markiftheregistranthaselectednottousetheextendedtransitionperiodforcomplyingwithanyneworrevisedfinancial accountingstandards†providedpursuanttoSection13(a)oftheExchangeAct. †Theterm“neworrevisedfinancialaccountingstandard”referstoanyupdateissuedbytheFinancialAccountingStandardsBoardtoitsAccountingStandardsCodificationafterApril5,2012. Indicatebycheckmarkwhethertheregistranthasfiledareportonandattestationtoitsmanagement’sassessmentoftheeffectivenessofitsinternalcontroloverfinancialreportingunderSection404(b)oftheSarbanes-OxleyAct(15U.S.C.7262(b))bytheregisteredpublicaccountingfirmthatpreparedorissueditsauditreport. YesNo IfsecuritiesareregisteredpursuanttoSection12(b)oftheAct,indicatebycheckmarkwhetherthefinancialstatementsoftheregistrantincludedinthefilingreflectthecorrectionofanerrortopreviouslyissuedfinancialstatements. Indicatebycheckmarkwhetheranyofthoseerrorcorrectionsarerestatementsthatrequiredarecoveryanalysisofincentive-basedcompensationreceivedbyanyoftheregistrant’sexecutiveofficersduringtherelevantrecoveryperiodpursuantto§240.10D-1(b). Indicatebycheckmarkwhichbasisofaccountingtheregistranthasusedtopreparethefinancialstatementsincludedinthisfiling: U.S.GAAPInternationalFinancialReportingStandardsasissuedOther bytheInternationalAccountingStandardsBoard If“Other”hasbeencheckedinresponsetothepreviousquestionindicatebycheckmarkwhichfinancialstatementitemtheregistranthaselectedtofollow.Item17Item18 Ifthisisanannualreport,indicatebycheckmarkwhethertheregistrantisashellcompany(asdefinedinRule12b-2oftheExchangeAct). YesNo (APPLICABLEONLYTOISSUERSINVOLVEDINBANKRUPTCYPROCEEDINGSDURINGTHEPASTFIVEYEARS) IndicatebycheckmarkwhethertheregistranthasfiledalldocumentsandreportsrequiredtobefiledbySections12,

你可能感兴趣

hot

医美国际2020年度报告

美股财报2021-04-30
hot

医美国际2021年度报告

美股财报2022-05-16
hot

医美国际2019年度报告

美股财报2020-04-30
hot

医美国际2022年度报告

美股财报2023-04-21
hot

小红书医美行业2023年度报告

医药生物
小红书2024-02-05